Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance

被引：48
作者：
Schneider, DJ [1 ]
机构：
[1] Univ Vermont, Colchester, VT 05446 USA
来源：
CORONARY ARTERY DISEASE | 2005年 / 16卷 / 08期
关键词：
coagulation; fibrinolysis; insulin resistance; plasminogen activator inhibitor type 1; platelets;
D O I：
10.1097/00019501-200512000-00003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Insulin resistance that accompanies obesity, hypertension, polycystic ovary syndrome, and the early phases of type 2 diabetes is characterized by a prothrombotic state. The prothrombotic state is a reflection of the direct effects of hyperinsulinemia and associated metabolic abnormalities (postprandial hyperglycemia, increased free fatty acids, and hypertriglyceridemia) on platelets, coagulation, and fibrinolysis. Therapies that improve insulin sensitivity and thereby decrease insulin resistance, hyperinsulinemia, and metabolic abnormalities decrease the prothrombotic state.
引用
收藏
页码：473 / 476
页数：4
相关论文
共 50 条
  • [31] Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus - Relationships to cardiovascular disease and risk factor intervention
    Lim, HS
    Blann, AD
    Lip, GYH
    [J]. CIRCULATION, 2004, 109 (21) : 2524 - 2528
  • [32] Elaboration of type-1 plasminogen activator inhibitor from adipocytes - A potential pathogenetic link between obesity and cardiovascular disease
    Lundgren, CH
    Brown, SL
    Nordt, TK
    Sobel, BE
    Fujii, S
    [J]. CIRCULATION, 1996, 93 (01) : 106 - 110
  • [33] Hyperinsulinemia, hyperglucemia, and impaired hemostasis - The Framingham offspring study
    Meigs, JB
    Mittleman, MA
    Nathan, DM
    Tofler, GH
    Singer, DE
    Murphy-Sheehy, PM
    Lipinsky, I
    D'Angostino, R
    Wilson, PWF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (02): : 221 - 228
  • [34] AUGMENTATION OF THE SYNTHESIS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 BY PRECURSORS OF INSULIN - A POTENTIAL RISK FACTOR FOR VASCULAR-DISEASE
    NORDT, TK
    SCHNEIDER, DJ
    SOBEL, BE
    [J]. CIRCULATION, 1994, 89 (01) : 321 - 330
  • [35] Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo
    Nordt, TK
    Sawa, H
    Fujii, S
    Bode, C
    Sobel, BE
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (08) : 1535 - 1543
  • [36] INDUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) BY PROINSULIN AND INSULIN IN-VIVO
    NORDT, TK
    SAWA, H
    FUJII, S
    SOBEL, BE
    [J]. CIRCULATION, 1995, 91 (03) : 764 - 770
  • [37] AUGMENTATION OF SYNTHESIS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN ARTERIAL ENDOTHELIAL-CELLS BY GLUCOSE AND ITS IMPLICATIONS FOR LOCAL FIBRINOLYSIS
    NORDT, TK
    KLASSEN, KJ
    SCHNEIDER, DJ
    SOBEL, BE
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (12): : 1822 - 1828
  • [38] Induction of plasminogen activator inhibitor type 1 and type 1 collagen expression in rat cardiac microvascular endothelial cells by interleukin-1 and its dependence on oxygen-centered free radicals
    Okada, H
    Woodcock-Mitchell, J
    Mitchell, J
    Sakamoto, T
    Marutsuka, K
    Sobel, BE
    Fujii, S
    [J]. CIRCULATION, 1998, 97 (21) : 2175 - 2182
  • [39] Insulin sensitivity, insulinemia, and coronary artery disease - The insulin resistance atherosclerosis study
    Rewers, M
    Zaccaro, D
    D'Agostino, R
    Haffner, S
    Saad, MF
    Selby, JV
    Bergman, R
    Savage, P
    [J]. DIABETES CARE, 2004, 27 (03) : 781 - 787
  • [40] Regulation of tissue factor gene expression in obesity
    Samad, F
    Pandey, M
    Loskutoff, DJ
    [J]. BLOOD, 2001, 98 (12) : 3353 - 3358
12345